北美自注射市场报告的规模、份额和趋势分析报告 - 行业趋势和2031年预测| 数据桥市场调研

自我注射市场分析

北美自我注射市场受到慢性病患病率上升、自我注射技术进步、患者自主性提高以及移动医疗应用兴起的驱动。该市场的特点是关键参与者的存在、持续的研究和开发以及战略合作。有利的监管环境和不断增加的医疗保健支出也支持了市场的扩张。自我注射设备，包括自动注射器、笔式注射器和可穿戴注射器，因其方便、易用以及能够通过允许患者在家中自行给药来提高患者依从性，从而减少频繁就医的需要，而变得越来越受欢迎。跟踪和监控患者依从性的连接设备等技术创新正在进一步推动市场增长。

自我注射市场规模

2023 年北美自我注射市场规模价值 195.2 亿美元，预计到 2031 年将达到 417.5 亿美元，2024 年至 2031 年预测期内的复合年增长率为 10.2%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

自我注射市场趋势

“更加关注用户友好型和一次性设备”

北美自我注射市场的一个主要趋势是对用户友好型一次性设备的需求不断增长。随着越来越多的患者管理糖尿病、类风湿性关节炎和多发性硬化症等慢性病，对易于使用的自我给药系统的需求也日益增长。自动注射器和预充式注射器等自我注射设备旨在通过简化注射过程来提高患者的依从性。这一趋势与更广泛的家庭护理转变相一致，鼓励患者更好地控制自己的治疗方案，减少频繁前往医疗机构的需要。

此外，技术进步也推动了该市场的创新。制造商正在将剂量跟踪和实时反馈等智能功能融入自我注射设备中。这些功能对于需要频繁注射的患者尤其有益，因为它们可以提高注射的精准度并降低注射不足或过量的风险。安全性、便利性和数字集成的增强可能会加速北美地区自我注射设备的普及，特别是在患者人数不断增长且医疗保健意识不断增强的地区。

报告范围和自我注射市场细分

属性	自我注射关键市场洞察
涵盖的领域	按产品类型：自我注射装置和自我注射配方按剂型分类：单剂量和多剂量按给药途径：皮下、肌肉内和其他按用途分类：自身免疫性疾病、疼痛管理、急救药物、肿瘤学、荷尔蒙失调等按年龄组：成人、老年人和儿童按性别：男性和女性按分销渠道：直接招标、医院药房、网上药房和其他
覆盖国家	美国、加拿大和墨西哥
主要市场参与者	拜耳公司 (德国)、UCB Pharma (比利时)、益普生生物制药公司 (法国)、Teva Pharmaceuticals Industries Ltd (以色列)、Recipharm AB (瑞典)、SCHOTT Pharma (德国)、礼来公司 (美国)、阿斯利康公司 (英国)、武田制药有限公司 (日本)、诺华公司 (瑞士)、辉瑞公司 (美国)、赛诺菲公司 (法国)、AbbVie (美国)、Biogen (美国)、YPSOMED (瑞士)、Bausch Health Companies Inc. (加拿大)、默克公司 (美国)、安进公司 (美国)、强生服务公司 (美国)、Penjet (美国)、PharmaJet (美国)、Societe Industrielle de Sonceboz SA (瑞士)、Terumo Corporation (日本)、Haselmeier (德国)、Owen Mumford (英国)、Midas Pharma GmbH (德国)、BD (美国)、 Phillips-Medisize（美国）、West Pharmaceutical Services（美国）、Gerresheimer AG（德国）、Enable Injections（美国）、Credence Medsystems, Inc.（美国）、Nemera（法国）、Oval Medical Technologies Ltd. (SMC Limited)（英国）、SHL Medical AG（瑞士）、Novo Nordisk A/S（丹麦）、AptarGroup, Inc.（美国）、Boehringer Ingelheim International GmbH（德国）、F. Hoffmann-La Roche Ltd（瑞士）和 GSK plc（英国）等
市场机会	生物制剂和个性化医疗的需求不断增长政府推动自我注射
增值数据信息集	除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解之外，Data Bridge Market Research 策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

自我注射市场定义

北美自我注射市场是指专注于开发、制造和分销设备和技术的行业，使患者能够自行用药，而无需医疗保健专业人员的直接参与。这些设备（例如自动注射器、预充式注射器、笔式注射器和可穿戴注射器）旨在提供各种治疗，包括生物制剂、胰岛素、激素和糖尿病、类风湿性关节炎和多发性硬化症等慢性病的治疗。该市场受到多种因素的推动，包括慢性病患病率的不断上升、对家庭医疗保健的日益偏好、对生物制剂和个性化医疗的需求不断增长，以及强调用户友好型设计、安全性和可靠性的药物输送技术的进步。

自我注射市场动态

驱动程序

慢性病患病率上升

糖尿病、关节炎和多发性硬化症等慢性病的日益流行是自我注射市场的主要驱动力。患有这些疾病的患者经常需要持续服药，因此自我注射设备既方便又必不可少。随着全球人口老龄化，对有效的家庭治疗方案的需求持续上升。自我注射系统使患者能够独立管理病情，大大减少了去医院就诊的需要。这种转变不仅提高了患者的依从性和生活质量，还减轻了医疗保健系统的负担，推动了市场的进一步增长。对个性化医疗保健解决方案的日益关注支持了自我注射技术的扩展，满足了寻求更大治疗方案自主权的多样化患者群体的需求。

例如，
2024 年 1 月，根据 NCBI 发表的文章，糖尿病和心脏病等慢性疾病是全球发病率和死亡率的主要原因，预计到 2030 年成本将达到 47 万亿美元。因此，糖尿病等慢性疾病的流行是市场发展的驱动力。

自我注射的技术进步

医疗技术的最新创新促成了先进的自我注射设备的诞生，这些设备优先考虑用户友好性和效率。自动注射器、预填充注射器和与移动应用程序集成的智能设备等功能通过提供实时反馈和提醒，显著提升了用户体验。这些改进提高了药物输送的准确性，降低了出错的可能性，使自我注射对患者更具吸引力。随着医疗保健日益转向以患者为中心的模式，对这些技术先进的解决方案的需求预计将上升。这一趋势可能会推动自我注射市场向前发展，满足寻求更大自主权和改善健康状况管理的患者的需求。这些创新不仅可以提高患者满意度，而且有助于改善整体健康结果。

例如，
根据 2023 年 10 月在 Frederick Furness Publishing 上发表的文章，它探索了创新解决方案，以应对注射高粘度药物的挑战，而这些药物通常很难通过传统设备输送。通过强调技术进步，它讨论了改进的注射器设计和自动输送系统如何提高自我注射的便利性和有效性，从而推动市场增长。

机会

政府推动自我注射

政府推动自我注射疗法的举措为全球自我注射市场带来了重大机遇。许多政府都致力于加强以患者为中心的医疗保健，减轻负担过重的医疗保健系统的压力。为了实现这一目标，一些国家医疗保健机构正在积极鼓励自我注射实践，为自我注射设备提供教育计划、补贴和监管支持。这些举措旨在使患者能够在家中管理慢性病，改善农村或医疗服务不足地区的治疗机会，减少医院就诊次数。此外，自我注射设备和药物的优惠报销政策进一步激励了患者和制造商。政府以资助创新自我注射技术研发的形式提供支持，同时简化了监管审批流程，加速了更安全、更用户友好的设备的普及。这种日益增长的政府支持通过为自我注射的采用创造有利环境来促进市场扩张，最终促进制造商和医疗保健提供商的增长潜力。

例如，

2023 年 10 月，根据联合国人口基金 (UNFPA) 发布的信息，联合国人口基金是致力于改善全球生殖健康和孕产妇健康的联合国机构，推动将注射用甲羟孕酮醋酸酯 - 皮下注射 (DMPA-SC) 作为自我注射避孕选择纳入印度国家计划生育计划，这是一个有希望且适时的机会，在解决妇女未满足的避孕需求方面发挥着至关重要的作用，特别是那些在获取避孕药具方面面临诸多障碍的弱势群体。自我注射在增强和多样化选择、促进自我护理实践方面发挥着至关重要的作用。

加强自我注射的研究和开发

通过推动创新以满足患者和医疗保健系统不断变化的需求，增加自我注射技术的研发 (R&D) 是全球自我注射市场的关键机遇。新兴的进步专注于创造更直观、用户友好的设备，以提高安全性、便利性和患者依从性。这些创新包括开发具有数字健康功能的智能注射器、无针系统和旨在更易于操作和减轻疼痛的自动注射器。此外，研发正在扩大可自我注射的注射药物范围，特别是在生物制剂、胰岛素和癌症治疗等领域，这增加了市场潜力。连接功能的集成使患者能够与医疗保健提供者共享实时数据，进一步增强了个性化的治疗体验，并与全球向以患者为中心的护理转变保持一致。随着制药公司和设备制造商对尖端技术的投资，这些进步不仅拓宽了自我注射设备的应用范围，而且还推动了采用并开辟了全球市场的新增长途径。

例如，

2023 年 5 月，根据 Springer 发表的文章，由 PHC Corporation（日本东京）开发的电动机械自动注射器 SMARTCLIC/CLICWISE 注射装置最近推出，用于皮下注射生物疗法。该设备的研发计划经过战略性设计，旨在打造一款用户友好、多用途的自动注射器，专门用于单个患者应用。这项创新旨在为患者和护理人员提供先进的给药选择，超越传统的自我注射方法，例如带有空注射器的药瓶、预充笔或注射器以及早期的自动注射器型号。

限制/挑战

自我注射器成本高昂

自我注射器的高成本限制了许多患者和医疗服务提供者的可及性，严重制约了全球自我注射市场的发展。尽管这些设备使用方便，可以减少就诊次数，但自动注射器和可穿戴系统等先进自我注射设备的价格昂贵，大部分人都负担不起，尤其是低收入地区或没有全面保险覆盖的人。这种经济障碍往往导致患者对处方治疗的依从性降低，因为许多人买不起长期使用所需的设备。此外，医疗系统可能不愿投资这些高成本的解决方案，这进一步减缓了这些解决方案的采用和市场渗透。因此，解决可负担性问题对于扩大自我注射技术的覆盖面和有效性至关重要。

例如，

2022 年 7 月，根据 NCBI 发表的文章，对于有过敏反应风险的患者来说，肾上腺素自动注射器的高昂成本对获得这种救命治疗构成了重大障碍。2014 年至 2020 年间，领先的自动注射器品牌 EpiPen 的标价上涨了两倍，而私人保险个人的年度自付费用则翻了一番。2019 年，每两包 Auvi-Q 的平均自付费用为 736 美元，品牌 EpiPen 为 63 美元，非品牌替代品仅为 10 美元。总体而言，2019 年，96,073 名患者（50.8%）的肾上腺素自动注射器年度自付费用为 200 美元，而 11,863 名患者（9.5%）的自付费用超过 500 美元。自我注射的高成本严重影响了患者获得和坚持必要的治疗。

自我注射设备的监管障碍和适当培训需求

监管障碍和对适当培训的需求是全球自我注射市场的主要制约因素，减缓了产品的可用性和采用。严格的法规和不同国家的审批程序各不相同，可能会延迟创新型自我注射设备的推出，因为制造商必须通过复杂且耗时的审批途径。这不仅阻碍了创新，也限制了这些产品的全球影响力。此外，即使获得监管部门批准，对适当培训的需求也成为一个障碍。自我注射设备要求患者和医疗保健提供者熟练掌握其使用方法，以确保安全性和有效性。如果没有全面的培训计划，患者可能会误用设备，导致剂量不当、健康风险和治疗依从性降低。医疗保健提供者还必须投入时间和资源来教育患者，这对已经捉襟见肘的医疗保健系统来说可能是一个负担。缺乏广泛的培训基础设施，尤其是在发展中地区，进一步限制了自我注射市场的潜在增长。因此，监管复杂性和患者教育需求都是阻碍市场扩张的关键因素。

例如，

2022年12月，根据NCBI发表的文章，笔式注射器的设计受到包括美国食品药品管理局在内的各政府机构的严格监管，必须遵守ISO 11608和ISO 60601等行业标准。这些法规要求进行广泛的测试，以确保输送的剂量与设定的剂量相匹配，尤其是对于多剂量笔式注射器。此外，制造商必须对设备和配方的所有组件进行生物相容性测试，评估潜在的可浸出物或可萃取物及其对胰岛素配方的影响。其他监管考虑因素包括保质期稳定性、环境条件对设备性能的影响、灭菌、可用性测试和目视检查能力。对于带有电子元件的智能笔，测试还必须考虑在各种环境条件下（例如热量和湿度）的性能，以确保安全性和准确性。

本市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需获取更多市场信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。

自我注射市场范围

市场根据产品类型、剂型、给药途径、应用、年龄组、性别和分销渠道进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品类型

自我注射装置
- 自动注射器
  - 一次性的
  - 可重复使用的
- 笔式注射器
  - 一次性的
  - 可重复使用的
- 可穿戴注射器
  - 一次性的
  - 可重复使用的
- 无针注射器
  - 一次性的
  - 可重复使用的
自注射配方

剂型

单剂量
多剂量

给药途径

皮下
肌肉内
其他的

应用

自身免疫性疾病
- 糖尿病
- 银屑病
- 多发性硬化症
- 其他的
疼痛管理
急救药品
- 呼吸治疗
- 偏头痛
- 过敏性休克
- 其他的
肿瘤学
荷尔蒙失调
- 骨质疏松症
- 性腺功能低下
- 肾上腺功能不全
- 其他的
其他的

年龄组

成人
老年
儿科

性别

男性
女性

分销渠道

直接招标
医院药房
网上药店
其他的

自我注射市场区域分析

对市场进行分析，并按国家、产品类型、剂型、给药途径、应用、年龄组、性别和分销渠道提供市场规模洞察和趋势。

市场覆盖的国家包括美国、加拿大和墨西哥。

由于美国拥有先进的医疗保健基础设施、慢性病的高发病率以及对创新医疗技术的大力采用，预计它将在市场中占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

自我注射市场份额

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、北美业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

在市场上运营的自我注射市场领导者是：

拜耳公司（德国）
UCB 制药公司（比利时）
Ipsen Biopharmaceuticals, Inc.（法国）
梯瓦制药工业有限公司 (以色列)
Recipharm AB（瑞典）
肖特制药（德国）
礼来（美国）
阿斯利康（英国）
武田药品工业株式会社 (日本)
诺华公司（瑞士）
辉瑞公司（美国）
赛诺菲（法国）
艾伯维 (美国)
Biogen（美国）
YPSOMED（瑞士）
Bausch Health Companies Inc.（加拿大）
默克公司（美国）
安进公司 (美国)
强生服务公司（美国）
Penjet（美国）
PharmaJet（美国）
Societe Industrielle de Sonceboz SA（瑞士）
泰尔茂株式会社 (日本)
哈泽尔迈尔（德国）
欧文·芒福德（英国）
Midas Pharma GmbH（德国）
BD（美国）
Phillips-Medisize（美国）
West Pharmaceutical Services（美国）
Gerresheimer AG（德国）
启用注射（美国）
Credence Medsystems, Inc.（美国）
Nemera（法国）
Oval Medical Technologies Ltd.（SMC Limited）（英国）
SHL Medical AG（瑞士）
诺和诺德公司（丹麦）
AptarGroup, Inc.（美国）
勃林格殷格翰国际有限公司 (德国)
F. Hoffmann-La Roche Ltd（瑞士）
葛兰素史克公司 (英国)

自我注射市场的最新发展

2024 年 9 月，Evotec 宣布与 Novo Nordisk 建立以细胞疗法为中心的技术开发合作伙伴关系后，股价上涨 6%。此次合作包括为德国和意大利的开发活动提供资金，以及预付款、潜在的里程碑成就和特许权使用费激励。Evotec 首席科学官 Cord Dohrmann 博士对通过这一合作伙伴关系创造创新的干细胞疗法表示乐观
2024 年 9 月，Tremfya (guselkumab) 获得 FDA 批准，用于治疗中度至重度活动性溃疡性结肠炎成人患者，此外还获准用于治疗斑块状银屑病和银屑病关节炎。它是首个针对该疾病的双效白细胞介素 23 抑制剂，在 QUASAR 研究中显示出显著的缓解率。以 200 毫克静脉诱导剂量给药，随后每 8 周皮下注射 100 毫克或每 4 周皮下注射 200 毫克维持剂量。此次批准彰显了强生致力于推进炎症性肠病治疗的承诺
2024 年 7 月，Biogen 收购了 Human Immunology Biosciences (HI-Bio)，通过有希望的治疗候选药物 felzartamab 增强了其免疫学产品线。此次收购将推动 felzartamab 进入针对各种适应症的 3 期试验。IgA 肾病和抗体介导排斥的 2 期研究报告了积极的中期结果
2024 年 7 月，Biogen 收购了 Human Immunology Biosciences (HI-Bio)，通过有希望的治疗候选药物 felzartamab 增强了其免疫学产品线。此次收购将推动 felzartamab 进入针对各种适应症的 3 期试验。IgA 肾病和抗体介导排斥的 2 期研究报告了积极的中期结果
2024 年 7 月，阿斯利康以高达 10.5 亿美元的价格成功收购了 Amolyt Pharma，增强了其 Alexion 罕见病产品线。其中包括用于治疗甲状旁腺功能减退症的 III 期肽类药物 eneboparatide，扩大了阿斯利康对罕见内分泌疾病和钙调节治疗的关注
2024 年 6 月，Aptar Digital Health 与 SHL Medical 合作，通过整合其 SaMD 平台增强联网设备技术。此次合作旨在改善患者在自行注射治疗过程中的体验，支持患者更好地遵守治疗并进行疾病管理

SKU-72900

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 NORTH AMERICA SELF-INJECTIONS MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 2 NORTH AMERICA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 3 NORTH AMERICA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 4 NORTH AMERICA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 5 NORTH AMERICA AUTO INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 6 NORTH AMERICA PEN INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 7 NORTH AMERICA WEARABLE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 8 NORTH AMERICA NEEDLE-FREE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 9 NORTH AMERICA SELF-INJECTION FORMULATION IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 10 NORTH AMERICA SELF-INJECTIONS MARKET, BY DOSAGE FORM, 2022-2031 (USD MILLION)

TABLE 11 NORTH AMERICA SINGLE DOSE IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 12 NORTH AMERICA MULTI-DOSE IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 13 NORTH AMERICA SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 14 NORTH AMERICA SUBCUTANEOUS IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 15 NORTH AMERICA INTRA MUSCULAR IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 16 NORTH AMERICA OTHERS IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 17 NORTH AMERICA SELF-INJECTIONS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 18 NORTH AMERICA AUTOIMMUNE DISEASES IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 19 NORTH AMERICA AUTOIMMUNE DISEASES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 20 NORTH AMERICA PAIN MANAGEMENT IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 21 NORTH AMERICA EMERGENCY DRUGS IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 22 NORTH AMERICA EMERGENCY DRUGS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 NORTH AMERICA ONCOLOGY IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 NORTH AMERICA HORMONAL DISORDERS IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 25 NORTH AMERICA HORMONAL DISORDERS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 26 NORTH AMERICA OTHERS IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 27 NORTH AMERICA SELF-INJECTIONS MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 28 NORTH AMERICA ADULT IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 NORTH AMERICA GERIATRIC IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 30 NORTH AMERICA PEDIATRIC IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 NORTH AMERICA SELF-INJECTIONS MARKET, BY GENDER, 2022-2031 (USD MILLION)

TABLE 32 NORTH AMERICA MALE IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 33 NORTH AMERICA FEMALE IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 34 NORTH AMERICA SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 35 NORTH AMERICA DIRECT TENDER IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 36 NORTH AMERICA HOSPITAL PHARMACY IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 37 NORTH AMERICA ONLINE PHARMACY IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 38 NORTH AMERICA OTHERS IN SELF-INJECTIONS MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 39 NORTH AMERICA SELF-INJECTIONS MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 40 NORTH AMERICA SELF-INJECTIONS MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 41 NORTH AMERICA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 42 NORTH AMERICA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 43 NORTH AMERICA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031(ASP)

TABLE 44 NORTH AMERICA AUTO INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 45 NORTH AMERICA PEN INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 46 NORTH AMERICA WEARABLE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 47 NORTH AMERICA NEEDLE-FREE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 48 NORTH AMERICA SELF-INJECTIONS MARKET, BY DOSAGE FORM, 2022-2031 (USD MILLION)

TABLE 49 NORTH AMERICA SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 50 NORTH AMERICA SELF-INJECTIONS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 51 NORTH AMERICA AUTOIMMUNE DISEASES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 52 NORTH AMERICA EMERGENCY DRUGS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 53 NORTH AMERICA HORMONAL DISORDERS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 54 NORTH AMERICA SELF-INJECTIONS MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 55 NORTH AMERICA SELF-INJECTIONS MARKET, BY GENDER, 2022-2031 (USD MILLION)

TABLE 56 NORTH AMERICA SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 57 U.S. SELF-INJECTIONS MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 58 U.S. SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 59 U.S. SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 60 U.S. SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031(ASP)

TABLE 61 U.S. AUTO INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 62 U.S. PEN INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 63 U.S. WEARABLE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 64 U.S. NEEDLE-FREE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 65 U.S. SELF-INJECTIONS MARKET, BY DOSAGE FORM, 2022-2031 (USD MILLION)

TABLE 66 U.S. SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 67 U.S. SELF-INJECTIONS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 68 U.S. AUTOIMMUNE DISEASES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 69 U.S. EMERGENCY DRUGS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 70 U.S. HORMONAL DISORDERS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 U.S. SELF-INJECTIONS MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 72 U.S. SELF-INJECTIONS MARKET, BY GENDER, 2022-2031 (USD MILLION)

TABLE 73 U.S. SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 74 CANADA SELF-INJECTIONS MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 75 CANADA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 76 CANADA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 77 CANADA SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031(ASP)

TABLE 78 CANADA AUTO INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 79 CANADA PEN INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 80 CANADA WEARABLE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 81 CANADA NEEDLE-FREE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 82 CANADA SELF-INJECTIONS MARKET, BY DOSAGE FORM, 2022-2031 (USD MILLION)

TABLE 83 CANADA SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 84 CANADA SELF-INJECTIONS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 85 CANADA AUTOIMMUNE DISEASES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 86 CANADA EMERGENCY DRUGS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 87 CANADA HORMONAL DISORDERS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 88 CANADA SELF-INJECTIONS MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 89 CANADA SELF-INJECTIONS MARKET, BY GENDER, 2022-2031 (USD MILLION)

TABLE 90 CANADA SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 91 MEXICO SELF-INJECTIONS MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 92 MEXICO SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 93 MEXICO SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 94 MEXICO SELF-INJECTION DEVICES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031(ASP)

TABLE 95 MEXICO AUTO INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 96 MEXICO PEN INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 MEXICO WEARABLE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 98 MEXICO NEEDLE-FREE INJECTORS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 99 MEXICO SELF-INJECTIONS MARKET, BY DOSAGE FORM, 2022-2031 (USD MILLION)

TABLE 100 MEXICO SELF-INJECTIONS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2031 (USD MILLION)

TABLE 101 MEXICO SELF-INJECTIONS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 102 MEXICO AUTOIMMUNE DISEASES IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 103 MEXICO EMERGENCY DRUGS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 104 MEXICO HORMONAL DISORDERS IN SELF-INJECTIONS MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 105 MEXICO SELF-INJECTIONS MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 106 MEXICO SELF-INJECTIONS MARKET, BY GENDER, 2022-2031 (USD MILLION)

TABLE 107 MEXICO SELF-INJECTIONS MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA SELF-INJECTIONS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA SELF-INJECTIONS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA SELF-INJECTIONS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA SELF-INJECTIONS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA SELF-INJECTIONS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA SELF-INJECTIONS MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA SELF-INJECTIONS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA SELF-INJECTIONS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA SELF-INJECTIONS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA SELF-INJECTIONS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 NORTH AMERICA SELF-INJECTIONS MARKET: SEGMENTATION

FIGURE 12 TWO SEGMENTS COMPRISE THE NORTH AMERICA SELF-INJECTIONS MARKET, BY PRODUCT TYPE

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 EXECUTIVE SUMMARY

FIGURE 15 SELF-INJECTION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA SELF-INJECTIONS MARKET IN 2024 & 2031

FIGURE 16 DROC ANALYSIS

FIGURE 17 NORTH AMERICA SELF-INJECTIONS MARKET: BY PRODUCT TYPE, 2023

FIGURE 18 NORTH AMERICA SELF-INJECTIONS MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 19 NORTH AMERICA SELF-INJECTIONS MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 20 NORTH AMERICA SELF-INJECTIONS MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 21 NORTH AMERICA SELF-INJECTIONS MARKET: BY DOSAGE FORM, 2023

FIGURE 22 NORTH AMERICA SELF-INJECTIONS MARKET: BY DOSAGE FORM, 2024-2031 (USD MILLION)

FIGURE 23 NORTH AMERICA SELF-INJECTIONS MARKET: BY DOSAGE FORM, CAGR (2024-2031)

FIGURE 24 NORTH AMERICA SELF-INJECTIONS MARKET: BY DOSAGE FORM, LIFELINE CURVE

FIGURE 25 NORTH AMERICA SELF-INJECTIONS MARKET: BY ROUTE OF ADMINISTRATION, 2023

FIGURE 26 NORTH AMERICA SELF-INJECTIONS MARKET: BY ROUTE OF ADMINISTRATION, 2024-2031 (USD MILLION)

FIGURE 27 NORTH AMERICA SELF-INJECTIONS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2024-2031)

FIGURE 28 NORTH AMERICA SELF-INJECTIONS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 NORTH AMERICA SELF-INJECTIONS MARKET: BY APPLICATION, 2023

FIGURE 30 NORTH AMERICA SELF-INJECTIONS MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 31 NORTH AMERICA SELF-INJECTIONS MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 32 NORTH AMERICA SELF-INJECTIONS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 33 NORTH AMERICA SELF-INJECTIONS MARKET: BY AGE GROUP, 2023

FIGURE 34 NORTH AMERICA SELF-INJECTIONS MARKET: BY AGE GROUP, 2024-2031 (USD MILLION)

FIGURE 35 NORTH AMERICA SELF-INJECTIONS MARKET: BY AGE GROUP, CAGR (2024-2031)

FIGURE 36 NORTH AMERICA SELF-INJECTIONS MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 37 NORTH AMERICA SELF-INJECTIONS MARKET: BY GENDER, 2023

FIGURE 38 NORTH AMERICA SELF-INJECTIONS MARKET: BY GENDER, 2024-2031 (USD MILLION)

FIGURE 39 NORTH AMERICA SELF-INJECTIONS MARKET: BY GENDER, CAGR (2024-2031)

FIGURE 40 NORTH AMERICA SELF-INJECTIONS MARKET: BY GENDER, LIFELINE CURVE

FIGURE 41 NORTH AMERICA SELF-INJECTIONS MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 42 NORTH AMERICA SELF-INJECTIONS MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 43 NORTH AMERICA SELF-INJECTIONS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 44 NORTH AMERICA SELF-INJECTIONS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 45 NORTH AMERICA SELF-INJECTIONS MARKET: SNAPSHOT (2023)

FIGURE 46 NORTH AMERICA SELF-INJECTIONS MARKET: COMPANY SHARE 2023 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What is the current market value for the North America Self-Injections Market?

The North America Self-Injections Market size was valued at USD 19.52 Billion in 2023.

What is the growth rate of the North America Self-Injections Market?

The North America Self-Injections Market is projected to grow at a CAGR of 10.2% from 2024 to 2031.

Which are the major market drivers for the market?

Rising prevalence of chronic disease and technological advancement in self injections are the major growth driving factors.

What are the major companies operating in this market?

Bayer AG (Germany), UCB Pharma (Belgium), Ipsen (France), Teva Pharmaceuticals (Israel), Recipharm (Sweden), Schott AG (Germany), Lilly (USA), AstraZeneca (UK-Sweden), Takeda Pharmaceuticals (Japan), Novartis AG (Switzerland), Pfizer (USA), Sanofi (France), AbbVie (USA), Biogen (USA), Ypsomed (Switzerland), Bausch Health (Canada), Merck & Co. (USA), Amgen (USA), Johnson & Johnson Services, Inc. (USA), Penjet Corporation (USA), Pharmajet, Inc. (USA), Sonceboz (Switzerland), Terumo Corporation (Japan), Haselmeier (Germany), Owen Mumford Ltd. (UK), Midas Pharma GmbH (Germany), BD (Becton, Dickinson and Company) (USA), Phillips-Medisize - A Molex Company (USA), West Pharmaceutical Services, Inc. (USA), E3D Elcam Drug Delivery Devices (Israel), Gerresheimer AG (Germany), Enable Injections (USA), Dali Medical Devices (Israel), Credence Medsystems, Inc. (USA), Nemera (France), Oval Medical Technologies Ltd. (SMC Limited) (UK), SHL Medical AG (Switzerland) are the major companies operating in this market.

Which countries data is covered in the market?

The countries covered in the market are U.S., Canada, and Mexico, U.K., Germany, France, Spain, Italy, Belgium, Russia, Switzerland, Netherlands, Turkey, Rest of Europe, China, Australia, Japan, India, Singapore, South Korea, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, and rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E., Israel, and rest of Middle East and Africa.

Forecast Period	2024 –2031
Market Size (Base Year)	USD 19.52 Billion
Market Size (Forecast Year)	USD 41.75 Billion
CAGR	10.20 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

北美自我注射市场规模、份额和趋势分析报告 – 行业趋势和 2031 年预测

北美自我注射市场规模、份额和趋势分析报告 – 行业趋势和 2031 年预测

North America Self Injections Market

CAGR : 10.20 %

自我注射市场分析

自我注射市场规模

自我注射市场范围

自我注射市场区域分析

自我注射市场份额

自我注射市场的最新发展

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

北美自我注射市场规模、份额和趋势分析报告 – 行业趋势和 2031 年预测

北美自我注射市场规模、份额和趋势分析报告 – 行业趋势和 2031 年预测

North America Self Injections Market

CAGR : 10.20 %

自我注射市场分析

自我注射市场规模

自我注射市场范围

自我注射市场区域分析

自我注射市场份额

自我注射市场的最新发展

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面